| Literature DB >> 27486358 |
Rajashree Patnaik1, Rabindra N Padhy1.
Abstract
This work describes that cytotoxicity of lead chloride and lead acetate to in vitro cultured lymphocytes from human umbilical cord blood, using four monitoring methods namely, trypan blue staining, acridine orange/ethidium bromide staining, 3-[4,5-dimethylthiazol-2-yl] 2,5-diphenyl tetrazolium bromide (MTT) and neutral red uptake assays; lead genotoxicity to lymphocytes was monitored by comet assay. The MIC value in each method was invariably 300 mg/L for PbCl2. Lethal concentration25 (LC25) values were almost in an agreeable range: 691.83 to 831.76 mg/L; LC50 values in each method were almost in the range: 1174.9 to 1348.9 mg/L; LC100 values were in the range: 3000 to 3300 mg/L, for lead chloride. Similarly, The MIC value in each method were invariably 150 mg/L; LC25 values were almost in the range: 295.12 to 371.53 mg/L; LC50 values were in the range: 501.18 to 588.84 mg/L; LC100 value was 1500 mg/L in all assays, for lead acetate. The comet assay also indicated that the LC100 values were 3300 mg/L lead chloride and 1500 mg/L lead acetate. Thus, both cytotoxicity and genotoxicity were recorded at 3300 mg/L lead chloride and 1500 mg/L lead acetate with lymphocytes.Entities:
Keywords: AO/EB staining; MTT assay; comet assay; cytotoxicity; genotoxicity; lead acetate; lead chloride
Year: 2015 PMID: 27486358 PMCID: PMC4961924 DOI: 10.1515/intox-2015-0007
Source DB: PubMed Journal: Interdiscip Toxicol ISSN: 1337-6853
Figure 1Density gradient centrifugation of human umbilical cord blood.
Figure 2Photomicrograph of growing lymphocytes; magnification, ×400.
Figure 3Probits of percentage lethality values plotted against log10 concentrations of PbCl2 and CH3COOPb (lead acetate) in the toxicity study of lymphocytes by MTT assay; each line is fitted by eye; three pairs of log10 concentration values were determined taking probit points, 4.3255 (LC25), 5.0000 (LC50) and 5.6745 (LC75).
Figure 4Histogram of MIC, LC25, LC50, LC75, HPC and LC100 values corresponding to TB, AO/EB, MTT, NRU and comet assay methods (see text for abbreviations) after the lymphocytes treated with PbCl2. M= mean value (mg/L).
Probit transformations of percent lethality values during PbCl2 toxicity to human lymphocytes growing in DME medium, assessed by four methods, TB, AO/EB staining, MTT assay, NRU assay and comet assay.
| PbCl2(ppm) | Log10 concen-tration of PbCl2 | PL of cells by TB staining | Probits of TB staining | PL of cells by AO/EB staining | Probits of AO/EB staining | PL of cells by MTT assay | Probits of MTT assay | PL of cells by NRU assay | Probits of NRU assay | DFI (%) | Probits of DFI |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 300 | 2.47 | 8.3 | 3.6 | 12 | 3.8 | 8.6 | 3.6 | 4.5 | 3.3 | 9 | 3.6 |
| 600 | 2.77 | 19.8 | 4.2 | 25 | 4.3 | 15.8 | 3.9 | 16.9 | 4.0 | 21 | 4.2 |
| 900 | 2.95 | 24.0 | 4.3 | 36 | 4.6 | 23.2 | 4.2 | 28.1 | 4.4 | 35 | 4.6 |
| 1200 | 3.07 | 36.6 | 4.6 | 42 | 4.7 | 41.3 | 4.7 | 40.5 | 4.7 | 41 | 4.7 |
| 1500 | 3.17 | 48.4 | 5.9 | 54 | 5.1 | 49.4 | 4.9 | 51.7 | 5.0 | 55 | 5.1 |
| 1800 | 3.25 | 60.3 | 5.2 | 70 | 5.5 | 59.5 | 5.2 | 64.1 | 5.3 | 69 | 5.4 |
| 2100 | 3.32 | 73.5 | 5.6 | 82 | 5.9 | 68.1 | 5.4 | 67.5 | 5.4 | 83 | 5.9 |
| 2400 | 3.38 | 85.0 | 6.0 | 89 | 6.2 | 86.3 | 6.1 | 79.8 | 5.8 | 91 | 6.3 |
| 2700 | 3.43 | 92.2 | 6.4 | 94 | 6.5 | 96.1 | 6.7 | 91.1 | 6.3 | 96 | 6.7 |
| 3000 | 3.47 | 100 | - | 100 | - | 98.6 | 7.1 | 93.3 | 6.4 | 100 | - |
| 3300 | 3.51 | - | - | - | - | 100 | - | 98.9 | 72 | - | - |
Note: TB, Trypan blue; AO/EB, Acridine orange/ethidium bromide; DMEM, Dulbecco's modified Eagle's medium; MTT, 3-[4, 5- dimethylthiazol-2-yl] 2,5-diphenyl tetrazolium bromide; NRU, Neutral red uptake assay; PL, Percent lethality; DFI, DNA fragmentation index; -, Not applicable. Experiments were repeated thrice and the last data set was presented.
Toxicity values of CH3COOPb to human lymphocytes obtained by experimentation and the probit computation.
| Toxicity values (mg/L) | ||||||
|---|---|---|---|---|---|---|
| Assay methods | MIC | LC25 | LC50 | LC75 | HPC | LC100 |
| TB staining | 150 | 295.12 | 588.84 | 851.13 | 1350 | 1500 |
| AO/EB staining | 150 | 338.84 | 512.86 | 954.99 | 1350 | 1500 |
| MTT assay | 150 | 371.53 | 524.81 | 707.94 | 1350 | 1500 |
| NRU assay | 150 | 323.59 | 501.18 | 707.94 | 1350 | 1500 |
| Comet assay | 150 | 331.13 | 512.86 | 758.57 | 1350 | 1500 |
Note: *From experiments
Toxicity values of PbCl2 to human lymphocytes obtained by experimentation and the probit computation.
| Toxicity values (mg/L) | ||||||
|---|---|---|---|---|---|---|
| Assay methods | MIC | LC25 | LC50 | LC75 | HPC | LC100 |
| TB staining | 300 | 831.76 | 1318.2 | 1995.3 | 2700 | 3000 |
| AO/EB staining | 300 | 758.57 | 1174.9 | 1698.2 | 2700 | 3000 |
| MTT assay | 300 | 691.83 | 1348.9 | 2344.2 | 3000 | 3300 |
| NRU assay | 300 | 707.94 | 1258.9 | 1995.3 | 3000 | 3300 |
| Comet assay | 300 | 812.83 | 1258.9 | 1737.8 | 2700 | 3000 |
Note: *From experiments
Figure 5Histogram of MIC, LC25, LC50, LC75, HPC and LC100 values corresponding to TB, AO/EB, MTT, NRU and comet assay methods (see text for abbreviations) after the cells treated with lead acetate. M= mean value (mg/L).
Figure 6AO/EB staining. Control cells (A); Cells after treated with 1500 mg/L PbCl2(B); Cells after treated with 1500 mg/L lead acetate (C).
Figure 7Comet assay. Control cells (A); Cells after treated with 1500 mg/L PbCl2 (B); Cells after treated with 1500 mg/L lead acetate (C).
Probit transformations of percent lethality values during CH3COOPb toxicity to human lymphocytes growing in DMEM, assessed by four methods, TB, AO/EB staining, MTT assay, NRU assay and comet assay.
| Conc. of CH3COOPb (mg/L) | Log10 concentration of CH3COOPb | PL of cells by TB staining | Probits of TB staining | PL of cells by AO/EB staining | Probits of AO/EB staining | PL of cells by MTT assay | Probits of MTT assay | PL of cells by NRU assay | Probits of NRU assay | DFI (%) | Probits of DFI |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | - | 0 | - | 0 | - | 0 | - | - | - | - | - |
| 150 | 2.17 | 16 | 4.0 | 12 | 3.8 | 13.6 | 3.9 | 12.1 | 3.8 | 11 | 3.7 |
| 300 | 2.47 | 24 | 4.3 | 21 | 4.2 | 20.2 | 4.2 | 20.3 | 4.2 | 20 | 4.1 |
| 450 | 2.65 | 39 | 4.7 | 33 | 4.6 | 34.6 | 4.6 | 32.3 | 4.5 | 32 | 4.5 |
| 600 | 2.77 | 47 | 4.9 | 46 | 4,9 | 39.1 | 4.7 | 40.5 | 4.7 | 47 | 4.9 |
| 750 | 2.87 | 56 | 5.2 | 52 | 5.1 | 59.5 | 5.2 | 51.9 | 5.0 | 53 | 5.1 |
| 900 | 2.95 | 67 | 5.4 | 61 | 5.3 | 77.1 | 5.7 | 62.3 | 5.3 | 64 | 5.3 |
| 1050 | 3.02 | 79 | 5.8 | 74 | 5.6 | 85.3 | 6.0 | 74.9 | 5.7 | 76 | 5.7 |
| 1200 | 3.07 | 86 | 6.1 | 89 | 6.2 | 94.4 | 6.6 | 84.7 | 6.0 | 88 | 6.1 |
| 1350 | 3.13 | 93 | 6.5 | 96 | 6.7 | 97.2 | 6.9 | 94.0 | 6.5 | 94 | 6.5 |
| 1500 | 3.17 | 100 | - | 100 | - | 98.3 | 7.1 | 97.9 | 7.0 | 100 | - |
Note: TB, Trypan blue; AO/EB, Acridine orange/ethidium bromide; DME medium, Dulbecco’s modified Eagle’s medium; MTT, 3-[4, 5- dimethylthiazol-2-yl] 2,5-diphenyl tetrazolium bromide; NRU, Neutral red uptake assay; PL, Percent lethality; DFI, DNA fragmentation index; –, Not applicable. Experiments were repeated thrice and the last data set was presented.